|
Name |
Neral
|
| Molecular Formula | C10H16O | |
| IUPAC Name* |
(2Z)-3,7-dimethylocta-2,6-dienal
|
|
| SMILES |
CC(=CCC/C(=C\C=O)/C)C
|
|
| InChI |
InChI=1S/C10H16O/c1-9(2)5-4-6-10(3)7-8-11/h5,7-8H,4,6H2,1-3H3/b10-7-
|
|
| InChIKey |
WTEVQBCEXWBHNA-YFHOEESVSA-N
|
|
| Synonyms |
NERAL; cis-Citral; Citral b; 106-26-3; (2Z)-3,7-dimethylocta-2,6-dienal; (Z)-3,7-Dimethylocta-2,6-dienal; (Z)-Citral; beta-Citral; (Z)-Neral; lemonal; Neroli aldehyde; 2,6-Octadienal, 3,7-dimethyl-, (Z)-; .beta.-Citral; 2,6-Octadienal, 3,7-dimethyl-, (2Z)-; 8M466BQL1X; (2Z)-3,7-Dimethyl-2,6-octadienal; cis-3,7-Dimethyl-2,6-octadienal; 2,6-Octadienal,3,7-dimethyl-, (2Z)-; citral-b; Z-Citral; UNII-8M466BQL1X; EINECS 203-379-2; CITRAL NERAL; AI3-28518; CITRAL NERAL [MI]; EC 203-379-2; SCHEMBL21491; CHEBI:29020; FEMA 2303; DTXSID60881216; cis-3,7-dimethyl-octa-2,6-dienal; ZINC12358789; LMPR0102010006; 5-Pyrimidinecarboxylic acid, 2-propyl-; (2Z)-3,7-dimethyl-2,6-octadien-1-al; 3,7-DIMETHYL-2,6-OCTADIENAL(CIS); C09847; Q27104033
|
|
| CAS | 106-26-3 | |
| PubChem CID | 643779 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 152.23 | ALogp: | 3.0 |
| HBD: | 0 | HBA: | 1 |
| Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 17.1 | Aromatic Rings: | 0 |
| Heavy Atoms: | 11 | QED Weighted: | 0.341 |
| Caco-2 Permeability: | -4.197 | MDCK Permeability: | 0.00002290 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0.002 |
| Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.637 |
| 30% Bioavailability (F30%): | 0.249 |
| Blood-Brain-Barrier Penetration (BBB): | 0.963 | Plasma Protein Binding (PPB): | 94.45% |
| Volume Distribution (VD): | 2.157 | Fu: | 6.26% |
| CYP1A2-inhibitor: | 0.852 | CYP1A2-substrate: | 0.274 |
| CYP2C19-inhibitor: | 0.363 | CYP2C19-substrate: | 0.833 |
| CYP2C9-inhibitor: | 0.071 | CYP2C9-substrate: | 0.438 |
| CYP2D6-inhibitor: | 0.052 | CYP2D6-substrate: | 0.195 |
| CYP3A4-inhibitor: | 0.026 | CYP3A4-substrate: | 0.242 |
| Clearance (CL): | 9.694 | Half-life (T1/2): | 0.691 |
| hERG Blockers: | 0.011 | Human Hepatotoxicity (H-HT): | 0.968 |
| Drug-inuced Liver Injury (DILI): | 0.232 | AMES Toxicity: | 0.739 |
| Rat Oral Acute Toxicity: | 0.963 | Maximum Recommended Daily Dose: | 0.183 |
| Skin Sensitization: | 0.902 | Carcinogencity: | 0.783 |
| Eye Corrosion: | 0.866 | Eye Irritation: | 0.984 |
| Respiratory Toxicity: | 0.971 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC001424 | ![]() |
1.000 | D0M1PQ | ![]() |
0.341 | ||
| ENC002413 | ![]() |
0.674 | D05XQE | ![]() |
0.328 | ||
| ENC001717 | ![]() |
0.674 | D09XWD | ![]() |
0.324 | ||
| ENC001718 | ![]() |
0.618 | D03VFL | ![]() |
0.259 | ||
| ENC001649 | ![]() |
0.600 | D0Q6DX | ![]() |
0.193 | ||
| ENC001719 | ![]() |
0.537 | D0F1GS | ![]() |
0.179 | ||
| ENC001720 | ![]() |
0.537 | D0Z4NI | ![]() |
0.179 | ||
| ENC001467 | ![]() |
0.500 | D0S7WX | ![]() |
0.178 | ||
| ENC001664 | ![]() |
0.468 | D03ZFG | ![]() |
0.177 | ||
| ENC001564 | ![]() |
0.468 | D0X7XG | ![]() |
0.174 | ||